ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Coronavirus

France probes new, potentially evasive COVID variant

Eight cases detected in Brittany but no sign yet this mutation is deadlier

There are worries that standard tests cannot detect a new variant of coronavirus found in Brittany in France.   © Reuters

PARIS (Reuters) -- Scientists are investigating a new coronavirus variant that has been detected in Brittany in western France that may evade testing more successfully than other versions, the regional health authority said on Tuesday.

Eight cases of the new variant were identified in a cluster in a Brittany hospital. France's health ministry said late on Monday that early analysis did not suggest the mutation was more contagious or more deadly than earlier versions of the virus.

"Investigations will take place to determine how this variant reacts to vaccination and to antibodies developed during prior COVID infections," Brittany's regional health authority said in a statement.

Scientists also want to understand if the variant can hide from testing after several of the patients delivered negative PCR tests and returned a positive result only from samples taken from blood or deep in the respiratory system.

Polymerase Chain Reaction tests are used to directly detect the presence of an antigen, rather than the presence of the body's immune response, or antibodies.

International agencies have been alerted to the discovery of the new variant.

Brittany has so far avoided the brunt of the third wave of infections sweeping through France and other European countries, but the incidence rate is rising.

The seven-day moving average of infections per 100,000 inhabitants in Brittany stood at 132.9 on March 12 compared with 113 a week earlier. The incidence rate in Paris and its surrounds, where intensive care wards are near saturation, stands at 404 per 100,000.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Try 1 month for $0.99

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to Nikkei Asia has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more